Biomarkers in lung cancer screening: the importance of study design.
作者信息
Baldwin David R, Callister Matthew E, Crosbie Philip A, O'Dowd Emma L, Rintoul Robert C, Robbins Hilary A, Steele Robert J C
机构信息
Respiratory Medicine, Nottingham University Hospitals, Nottingham, UK
University of Nottingham, Nottingham, UK.
出版信息
Eur Respir J. 2021 Jan 14;57(1). doi: 10.1183/13993003.04367-2020. Print 2021 Jan.
Abstract
摘要
相似文献
1
Biomarkers in lung cancer screening: the importance of study design.肺癌筛查中的生物标志物：研究设计的重要性。
Eur Respir J. 2021 Jan 14;57(1). doi: 10.1183/13993003.04367-2020. Print 2021 Jan.
2
National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers.国家肺癌筛查试验美国放射学院影像学网络标本生物库源自当代肺癌筛查试验（NLST，ACRIN 6654）：设计、意图和验证肺癌生物标志物的标本可用性。
J Thorac Oncol. 2010 Oct;5(10):1502-6. doi: 10.1097/JTO.0b013e3181f1c634.
3
Biomarkers for Lung Cancer Screening and Detection.肺癌筛查和检测的生物标志物。
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2411-2415. doi: 10.1158/1055-9965.EPI-20-0865. Epub 2020 Oct 22.
4
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges.肺癌筛查中的生物标志物：成就、前景与挑战。
J Thorac Oncol. 2019 Mar;14(3):343-357. doi: 10.1016/j.jtho.2018.11.023. Epub 2018 Dec 4.
5
Molecular biomarkers for future screening of lung cancer.用于未来肺癌筛查的分子生物标志物。
J Surg Oncol. 2013 Oct;108(5):327-33. doi: 10.1002/jso.23382. Epub 2013 Jul 25.
6
[Present Situation of Lung Cancer Screening Methods].[肺癌筛查方法的现状]
Zhongguo Fei Ai Za Zhi. 2016 Oct 20;19(10):715-720. doi: 10.3779/j.issn.1009-3419.2016.10.14.
7
Noninvasive Diagnostics for Early Detection of Lung Cancer: Challenges and Potential with a Focus on Changes in DNA Methylation.非侵入性诊断用于早期肺癌检测：以 DNA 甲基化变化为重点的挑战与潜力
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2416-2422. doi: 10.1158/1055-9965.EPI-20-0704. Epub 2020 Nov 4.
8
Apo10 and TKTL1 in blood macrophages as biomarkers for differentiating lung cancer from benign lung lesions: a comparative study with conventional biomarkers.血液巨噬细胞中的 Apo10 和 TKTL1 作为区分肺癌与良性肺病变的生物标志物：与常规生物标志物的比较研究。
Cell Oncol (Dordr). 2023 Dec;46(6):1725-1729. doi: 10.1007/s13402-023-00838-1. Epub 2023 Jun 28.
9
Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.评估用于肺癌早期检测的分子生物标志物：生物标志物何时可用于临床？美国胸科学会官方政策声明。
Am J Respir Crit Care Med. 2017 Oct 1;196(7):e15-e29. doi: 10.1164/rccm.201708-1678ST.
10
Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.循环肿瘤细胞作为肺癌潜在筛查工具的研究（AIR研究）：法国一项前瞻性多中心队列研究方案
BMJ Open. 2017 Dec 26;7(12):e018884. doi: 10.1136/bmjopen-2017-018884.
引用本文的文献
1
High-Throughput Peptide Array Clinical Validation for Lung Adenocarcinoma Detection.用于肺癌腺癌检测的高通量肽阵列临床验证
ACS Omega. 2025 May 12;10(21):21857-21866. doi: 10.1021/acsomega.5c01737. eCollection 2025 Jun 3.
2
Five year mortality in an RCT of a lung cancer biomarker to select people for low dose CT screening.一项关于肺癌生物标志物用于选择人群进行低剂量CT筛查的随机对照试验中的五年死亡率。
PLoS One. 2025 Jan 8;20(1):e0306163. doi: 10.1371/journal.pone.0306163. eCollection 2025.
3
Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment.肺癌筛查中的蛋白质生物标志物：技术考虑因素和可行性评估。
Arch Bronconeumol. 2024 Oct;60 Suppl 2:S67-S76. doi: 10.1016/j.arbres.2024.07.007. Epub 2024 Jul 17.
4
Health Economic Evaluation of Lung Cancer Screening Using a Diagnostic Blood Test: The Early Detection of Cancer of the Lung Scotland (ECLS).使用诊断性血液检测进行肺癌筛查的卫生经济学评价：苏格兰肺癌早期检测（ECLS）。
Curr Oncol. 2024 Jun 18;31(6):3546-3562. doi: 10.3390/curroncol31060261.
5
The Role of Biomarkers in Lung Cancer Screening.生物标志物在肺癌筛查中的作用。
Cancers (Basel). 2024 May 23;16(11):1980. doi: 10.3390/cancers16111980.
6
Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer.当前和未来视角下的肺癌计算机断层扫描筛查：2023 至 2027 年国际肺癌研究协会路线图
J Thorac Oncol. 2024 Jan;19(1):36-51. doi: 10.1016/j.jtho.2023.07.019. Epub 2023 Jul 23.
7
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program.在肺癌病因和风险综合分析（INTEGRAL）计划中进行生物标志物发现和验证的设计和方法学考虑。
Ann Epidemiol. 2023 Jan;77:1-12. doi: 10.1016/j.annepidem.2022.10.014. Epub 2022 Oct 29.
8
Implementing Lung Cancer Screening in Europe: Taking a Systems Approach.在欧洲实施肺癌筛查：采用系统方法。
JTO Clin Res Rep. 2022 Apr 22;3(5):100329. doi: 10.1016/j.jtocrr.2022.100329. eCollection 2022 May.
本文引用的文献
1
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.利用游离 DNA 中的甲基化特征进行敏感且特异的多癌种检测和定位。
Ann Oncol. 2020 Jun;31(6):745-759. doi: 10.1016/j.annonc.2020.02.011. Epub 2020 Mar 30.
2
Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals.基于甲基化的新型血液检测方法Lung EpiCheck在欧洲和中国高危个体中用于肺癌检测的验证。
Eur Respir J. 2021 Jan 14;57(1). doi: 10.1183/13993003.02682-2020. Print 2021 Jan.
3
Low molecular weight serum cell-free DNA concentration is associated with clinicopathologic indices of poor prognosis in women with uterine cancer.低分子量血清游离DNA浓度与子宫癌女性患者预后不良的临床病理指标相关。
J Transl Med. 2020 Aug 27;18(1):323. doi: 10.1186/s12967-020-02493-8.
4
Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.在一项先进行自身抗体血液检测随后进行成像的随机试验中对肺癌进行早期诊断。
Eur Respir J. 2021 Jan 14;57(1). doi: 10.1183/13993003.00670-2020. Print 2021 Jan.
5
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.循环肿瘤细胞作为肺癌筛查的潜在生物标志物：一项前瞻性队列研究。
Lancet Respir Med. 2020 Jul;8(7):709-716. doi: 10.1016/S2213-2600(20)30081-3.
6
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.血液检测结合 PET-CT 筛查癌症并指导干预的可行性。
Science. 2020 Jul 3;369(6499). doi: 10.1126/science.abb9601. Epub 2020 Apr 28.
7
Integrating genomic features for non-invasive early lung cancer detection.整合基因组特征进行非侵入性早期肺癌检测。
Nature. 2020 Apr;580(7802):245-251. doi: 10.1038/s41586-020-2140-0. Epub 2020 Mar 25.
8
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.随机试验中 CT 容积筛查降低肺癌死亡率
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
9
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.国家肺癌筛查试验中延长随访后的肺癌发病率和死亡率。
J Thorac Oncol. 2019 Oct;14(10):1732-1742. doi: 10.1016/j.jtho.2019.05.044. Epub 2019 Jun 28.
10
Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.低剂量计算机断层扫描（LDCT）筛查降低肺癌死亡率-来自德国 LUSI 随机试验的结果。
Int J Cancer. 2020 Mar 15;146(6):1503-1513. doi: 10.1002/ijc.32486. Epub 2019 Jun 20.
Zotero 插件